VERADIGM INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.96 USD | +0.13% |
|
+4.74% | -24.12% |
| 03/04 | Veradigm and Vim Announce Strategic Collaboration to Improve Payer-Provider Collaboration | CI |
| 19/03 | Deutsche Bank Downgrades Veradigm to Hold From Buy, Adjusts Price Target to $10 From $15 | MT |
| Sales 2022 * | 617M 51.44B | Sales 2023 * | 625M 52.08B | Capitalization | 857M 71.44B |
|---|---|---|---|---|---|
| Net income 2022 * | -4M -334M | Net income 2023 * | - | EV / Sales 2022 * | 0.27 x |
| Net cash position 2022 * | 692M 57.68B | Net cash position 2023 * | 728M 60.66B | EV / Sales 2023 * | 0.21 x |
| P/E ratio 2022 * |
-398
x | P/E ratio 2023 * |
23.4
x | Employees | 8,000 |
| Yield 2022 * |
-
| Yield 2023 * |
-
| Free-Float | 38.21% |
More Fundamentals
* Assessed data
More news
Latest transcript on Veradigm Inc.
More recommendations
More press releases
More news
| 1 day | +0.13% | ||
| 1 week | +4.74% | ||
| Current month | +3.38% | ||
| 1 month | +2.05% | ||
| 3 months | -15.32% | ||
| 6 months | -36.78% | ||
| Current year | -24.12% |
1 week
7.41
8.26
1 month
7.408.49
Current year
5.0111.05
1 year
5.0114.09
3 years
5.0123.25
5 years
4.5623.25
10 years
4.5623.25
| Managers | Title | Age | Since |
|---|---|---|---|
Shih-Yin Ho
CEO | Chief Executive Officer | 54 | 17/23/17 |
Thomas Langan
PSD | President | 58 | 01/18/01 |
| Director of Finance/CFO | 55 | 07/12 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Susan Rodriguez
BRD | Director/Board Member | 60 | 17/23/17 |
Jonathan Judge
BRD | Director/Board Member | 70 | 24/16/24 |
David Stevens
BRD | Director/Board Member | 62 | 24/16/24 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.50% | 29 M€ | -4.33% | ||
| 0.43% | 27 M€ | -5.03% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 7.96 | +0.13% | 249,847 |
| 25/24/25 | 7.95 | -1.00% | 61,088 |
| 24/24/24 | 8.03 | +1.01% | 755,636 |
| 23/24/23 | 7.95 | +3.52% | 941,052 |
| 22/24/22 | 7.68 | +1.05% | 243,838 |
Delayed Quote OTC Markets, April 27, 2024 at 01:29 am IST
More quotes
Veradigm Inc. is a healthcare data and technology solutions technology company. The Company is focused on research, analytics, and building scalable data-driven solutions. It combines data-driven clinical insights with actionable tools to enable healthcare stakeholders improve the value of healthcare delivery. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. Its Veradigm Network Solutions include Veradigm Real World Data, Veradigm Real World Evidence, Veradigm Digital Health Media, and Evalytica. Its health plan and payer solutions include eCHART COURIER, Veradigm Payer Insights, and Risk Adjustment & Quality Analytics. Its healthcare provider solutions include Veradigm Practice Management, Veradigm Payerpath, and Electronic Health Records. It also provides full-service revenue cycle management.
Calendar
Related indices
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
7.96
USD
Average target price
15
USD
Spread / Average Target
+88.44%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -24.12% | 857M | |
| +4.36% | 32.47B | |
| +14.14% | 7.45B | |
| +22.93% | 3.89B | |
| -16.29% | 3.17B | |
| -25.96% | 1.28B | |
| -36.14% | 1.09B | |
| -35.42% | 902M | |
| -0.13% | 893M | |
| -18.47% | 693M |
- Stock Market
- Equities
- MDRX Stock
